AIM ImmunoTech (AIM) Tops Q2 EPS by 10c

AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($0.03), $0.10 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.

You May Also Be Interested In

• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
• Active options: NFLX CORZ NOK SOFI WMT NKE SNDK MRVL
• Increasing unusual call volume: INTW GO RSP AKBA SRE XERS CGNX PEW VERA BLZE CPSH SOLS CXW UA